(Q36187269)
Statements
ERK1/2 activation is a therapeutic target in age-related macular degeneration (English)
Sami Dridi
Yoshio Hirano
Younghee Kim
Benjamin J Fowler
Balamurali K Ambati
Sasha Bogdanovich
Vince A Chiodo
Jennifer F Kugel
James A Goodrich
Steven L Ponicsan
David R Hinton
Mark E Kleinman
Judit Z Baffi
Bradley D Gelfand
Jayakrishna Ambati
6 August 2012
13781-13786
1 reference